ArticleBMC infectious diseases2026
Unsuppressed viral load and its associated factors among people living with HIV on antiretroviral therapy: a cross-sectional study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to assess the prevalence of unsuppressed viral load and its associated factors among people living with HIV (PLWH) receiving antiretroviral therapy (ART) in the Xinjiang Production and Construction Corps (XPCC).
methodsClinical data and questionnaires were collected from four divisions of the XPCC via random sampling. Logistic regression and mediation analyses were performed to identify factors associated with unsuppressed viral load.
resultsAmong 369 PLWH, 55 (14.91%) had unsuppressed viral load. Associated factors included CD4+ T-cell count ≥ 500 cells/μL, treatment duration ≥ 3 years, alcohol consumption, discrimination, poor ART adherence, and poor self-efficacy (all p < 0.05). ART adherence played a full mediating role between self-efficacy, social support and unsuppressed viral load in PLWH, with a mediation effect value (a*b) of β = -0.010 (95% CI: -0.013, -0.006) and β = -0.021 (95% CI: -0.029, -0.014). Greater social support and higher self-efficacy reduce the risk of unsuppressed viral load in PLWH via improved ART adherence. Additionally, the "social support ⇒ medication adherence" pathway exerted a partial chain mediating role between self-efficacy and viral load suppression in PLWH, with a mediation effect value (a*b) of β = -0.012 (95% CI :-0.017, -0.006).Social support can first enhance patients' self-efficacy, which in turn further improves ART adherence, thereby reducing the risk of unsuppressed viral load.
conclusionsIn the XPCC, the viral suppression rate among PLWH has not yet met the UNAIDS 95-95-95 target. Priority should be given to PLWH with <3 years of treatment and CD4+ T-cell count < 500 cells/μL. HIV-related education should be delivered to individuals, families and the public to enhance social support and self-efficacy, reduce HIV-related stigma, and promote healthy lifestyles (e.g. reduced alcohol consumption). These measures will improve adherence to ART, thereby achieving effective viral load suppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.